Alvotech stock has dropped despite strong fundamentals and rapid sales growth. Read about ALVO's projected revenue, debt ...

Teva Pharmaceutical Industries Limited’s TEVA shares have risen 21.6% in three months. Over the past few quarters, Teva has ...

Alvotech, a global biotech company specializing in the development and manufacture of biosimilars, has appointed Linda ...

Joel Morales, who has served as CFO of Alvotech since 2020, based in the U.S., has decided to step down. He will continue supporting Alvotech in an advisory capacity to ensure a smooth transition.

Linda Jónsdóttir Linda Jonsdottir, Alvotech's new Chief Financial Officer REYKJAVIK, ICELAND (July 10, 2025) — Alvotech ...

Ivers-Lee’s assembly and packaging capabilities will be integrated into Alvotech's Technical Operations division.

Alvotech acquires Swiss packaging firm Ivers-Lee to boost biosimilar production capacity ahead of three 2025 launches.

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...

Alvotech and Advanz Pharma expand their European biosimilar partnership to include AVT10, targeting Cimzia® for rheumatic ...

Alvotech & Advanz Pharma ink European supply and commercialization agreement for biosimilar candidate to Cimzia: Reykjavik, Iceland Wednesday, July 2, 2025, 09:00 Hrs [IST] Alvote ...

Alvotech (NASDAQ: ALVO, the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that its lenders under ...

An EMA committee has recommended approval of Alvotech’s AVT06, a biosimilar to Bayer’s blockbuster ophthalmology drug Eylea.